Wouter Bult
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Intravenous Infusion Technology and Safety 2
- Co-authors
- J. Frank W. Nijsen (7 shared papers)Wim E. Hennink (5 shared papers)Chris Oerlemans (1 shared paper)Gert Storm (1 shared paper)Alfred D. van het Schip (8 shared papers)M. A. D. Vente (4 shared papers)Bernard A. Zonnenberg (3 shared papers)Peter R. Seevinck (5 shared papers)
- Journals
- Pharmaceutical Research (4 papers)PLoS ONE (2 papers)International Journal of Clinical Pharmacy (1 paper)Journal of Chromatography B (1 paper)BMC Medical Informatics and Decision Making (1 paper)
- Partner nations
- NetherlandsGermanyDenmark
In The Last Decade
Wouter Bult
20 papers receiving 1.1k citations
Wouter Bult's Hit Papers
Peers
Comparison fields: 5 of 115
- Biomaterials 507
- Molecular Medicine 63
- Hepatology 90
- Pharmaceutical Science 75
- Biomedical Engineering 318
Countries citing papers authored by Wouter Bult
This map shows the geographic impact of Wouter Bult's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Bult with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Bult more than expected).
Fields of papers citing papers by Wouter Bult
This network shows the impact of papers produced by Wouter Bult. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Bult. The network helps show where Wouter Bult may publish in the future.
Co-authors
The 25 scholars most cited alongside Wouter Bult, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release Hit paper breakdown → | 2010 | 736 |
| 2 | 2010 | 79 | |
| 3 | 2009 | 32 | |
| 4 | Microsphere radioembolization of liver malignancies: current developments. | 2009 | 31 |
| 5 | 2013 | 30 | |
| 6 | 2010 | 24 | |
| 7 | 2009 | 24 | |
| 8 | 2011 | 20 | |
| 9 | 2020 | 15 | |
| 10 | 2012 | 14 | |
| 11 | 2019 | 13 | |
| 12 | 2019 | 12 | |
| 13 | 2014 | 11 | |
| 14 | 2019 | 10 | |
| 15 | 2019 | 10 | |
| 16 | 2020 | 8 | |
| 17 | 2017 | 8 | |
| 18 | 2020 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2020 | 2 |
About Wouter Bult
Wouter Bult is a scholar working on Hepatology, Biomedical Engineering, Cardiology and Cardiovascular Medicine, Surgery and Pharmacology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Patient Safety and Medication Errors (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Intravenous Infusion Technology and Safety (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). The work is most often cited by research in Biomaterials (507 citations), Molecular Medicine (63 citations), Hepatology (90 citations), Pharmaceutical Science (75 citations) and Biomedical Engineering (318 citations). Wouter Bult has collaborated with scholars based in Netherlands, Germany and Denmark. Frequent co-authors include J. Frank W. Nijsen, Wim E. Hennink, Chris Oerlemans, Gert Storm, Alfred D. van het Schip, M. A. D. Vente, Bernard A. Zonnenberg, Peter R. Seevinck, Chris J.G. Bakker and Mattijs Elschot. Their work appears in journals such as Pharmaceutical Research, PLoS ONE, International Journal of Clinical Pharmacy, Journal of Chromatography B and BMC Medical Informatics and Decision Making.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.